Mateon Therapeutics Inc (MATN):企業の財務・戦略的SWOT分析

◆英語タイトル:Mateon Therapeutics Inc (MATN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14890
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mateon Therapeutics Inc (Mateon), formerly OXiGENE Inc is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications. The company develops therapeutics to treat cancer and eye diseases; and anti-vascular drugs such as vascular disrupting agents. It is developing a product for treatment of anaplastic thyroid cancer, medullary thyroid cancer, stage IV papillary thyroid cancer, ovarian cancer, stage IV follicular thyroid cancer, and others. Mateon offers development pipeline such as CA4P and Oxi4503. The company also conducts multiple clinical trials in oncology to discover small-molecule anticancer agents belong to benzosuberene class of compound. It operates through researchers in the University of Florida and the University of Arhus on anti-angiogenic and anti-metastatic agents. Oxigene is headquartered in South San Francisco, California, the US.

Mateon Therapeutics Inc Key Recent Developments

Nov 14,2018: Mateon Therapeutics announces third quarter 2018 financial results
Aug 14,2018: Mateon Therapeutics reports second quarter 2018 financial results
May 14,2018: Mateon Therapeutics Reports First Quarter 2018 Financial Results
Apr 16,2018: Mateon Therapeutics Reports 2017 Financial Results

This comprehensive SWOT profile of Mateon Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mateon Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Mateon Therapeutics Inc – Key Information
Mateon Therapeutics Inc – Overview
Mateon Therapeutics Inc – Key Employees
Mateon Therapeutics Inc – Key Employee Biographies
Mateon Therapeutics Inc – Key Operational Heads
Mateon Therapeutics Inc – Major Products and Services
Mateon Therapeutics Inc – History
Mateon Therapeutics Inc – Company Statement
Mateon Therapeutics Inc – Locations And Subsidiaries
Mateon Therapeutics Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Mateon Therapeutics Inc – Business Description
Mateon Therapeutics Inc – Corporate Strategy
Mateon Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Mateon Therapeutics Inc – Strengths
Mateon Therapeutics Inc – Weaknesses
Mateon Therapeutics Inc – Opportunities
Mateon Therapeutics Inc – Threats
Mateon Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Mateon Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Mateon Therapeutics Inc, Key Information
Mateon Therapeutics Inc, Key Ratios
Mateon Therapeutics Inc, Share Data
Mateon Therapeutics Inc, Major Products and Services
Mateon Therapeutics Inc, History
Mateon Therapeutics Inc, Key Employees
Mateon Therapeutics Inc, Key Employee Biographies
Mateon Therapeutics Inc, Key Operational Heads
Mateon Therapeutics Inc, Other Locations
Mateon Therapeutics Inc, Subsidiaries
Mateon Therapeutics Inc, Key Manufacturing facilities
Mateon Therapeutics Inc, Key Competitors
Mateon Therapeutics Inc, SWOT Analysis
Mateon Therapeutics Inc, Ratios based on current share price
Mateon Therapeutics Inc, Annual Ratios
Mateon Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Mateon Therapeutics Inc, Performance Chart
Mateon Therapeutics Inc, Ratio Charts

★海外企業調査レポート[Mateon Therapeutics Inc (MATN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Foamix Pharmaceuticals Ltd (FOMX):製薬・医療:M&Aディール及び事業提携情報
    Summary Foamix Pharmaceuticals Ltd (Foamix), formerly Foamix Ltd is a pharmaceutical company that develops and commercializes proprietary topical drugs for various dermatological therapies. The company’s product candidates include FMX101, a minocycline foam which is intended for the treatment of mod …
  • Interconexion Electrica S.A. E.S.P.:発電所・企業SWOT分析
    Interconexion Electrica S.A. E.S.P. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Syndicate Bank Ltd (SYNDIBANK):企業の財務・戦略的SWOT分析
    Syndicate Bank Ltd (SYNDIBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • AIG Europe Limited:企業の戦略・SWOT・財務情報
    AIG Europe Limited - Strategy, SWOT and Corporate Finance Report Summary AIG Europe Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • IBERIABANK Corporation:企業のM&A・事業提携・投資動向
    IBERIABANK Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IBERIABANK Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Vedanta Resources Plc:企業の戦略・SWOT・財務分析
    Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Korea Electric Power Corporation:発電所・企業SWOT分析
    Korea Electric Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Encision Inc (ECIA):企業の財務・戦略的SWOT分析
    Summary Encision Inc (Encision) is a medical device company that manufactures and markets surgical instruments. The company provides laparoscopic monopolar surgical instruments. Its product portfolio includes AEM burn protection systems, AEM instrumentation, cord adapter, inhibit adapter extension, …
  • Haworth Inc:企業の戦略的SWOT分析
    Haworth Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Synlogic Inc (SYBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Synlogic Inc (Synlogic), formerly TMC Therapeutics Inc is a clinical stage drug development company that develops novel class of living medicines for the treatment of rare and genetic metabolic diseases, by applying synthetic biology to probiotics. The company’s pipeline includes SYNB1020 a …
  • Chugai Pharmaceutical Co Ltd (4519):製薬・医療:M&Aディール及び事業提携情報
    Summary Chugai Pharmaceutical Co Ltd (Chugai) is a subsidiary of Hoffmann-La Roche Ltd, which focuses on the research, development, manufacture, commercialization, import and export of the biopharmaceuticals and therapeutic antibodies. The company offers products for the treatment of cancer; bone an …
  • Yihai International Holding Ltd (1579):企業の財務・戦略的SWOT分析
    Yihai International Holding Ltd (1579) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • TFS Financial Corporation:企業の戦略・SWOT・財務情報
    TFS Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary TFS Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nisshinbo Holdings Inc. (3105):企業の財務・戦略的SWOT分析
    Nisshinbo Holdings Inc. (3105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • MediaTek Inc.:企業の戦略・SWOT・財務情報
    MediaTek Inc. - Strategy, SWOT and Corporate Finance Report Summary MediaTek Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Alion Science and Technology Corporation:戦略・SWOT・企業財務分析
    Alion Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Alion Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • TransCanada Corporation (TRP):電力:M&Aディール及び事業提携情報
    Summary TransCanada Corp (TransCanada) is an energy infrastructure company. It develops and operates energy infrastructure, such as natural gas and liquids pipelines, power generation and gas storage facilities. The company also provides gas storage related services and operates in the regulated and …
  • Gas y Petroleo del Neuquen SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Gas y Petroleo del Neuquen SA (Gas Y Petroleo) operates as an oil and gas exploration company. It is engaged in the production and supply of hydrocarbon resources. The company holds 36 contracts with other companies, to develop exploratory and hydrocarbon exploitation activities. It is also …
  • InTouch Technologies Inc:企業の戦略的SWOT分析
    InTouch Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Dev Information Technology Limited (DEVIT):企業の財務・戦略的SWOT分析
    Dev Information Technology Limited (DEVIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆